Federal and Minnesota Drug Laws and Schedules
The two layers
Federal law (CSA) places controlled substances in Schedules I–V; Minnesota codifies its own schedules in Minn. Stat. 152.02 and the Board of Pharmacy maintains them. The state schedule controls Minnesota licensure and dispensing consequences. The schedules are usually aligned with federal law but are separate, so when a substance's status is questioned, check the Minnesota schedule rather than relying on federal scheduling alone.
Core federal rules
Schedule II: no refills; a new prescription is required. An emergency oral C-II order may be filled only for the emergency quantity, and the prescriber must supply a written prescription within 7 days or the pharmacist must notify DEA. C-III–V: maximum five refills or six months from the date of issue, whichever comes first. Pharmacies obtain C-II stock with DEA Form 222 (or CSOS), keep a biennial inventory, and retain records at least two years.
Minnesota additions
Minnesota's Prescription Monitoring Program requires dispensers to report controlled substance dispensings electronically; prescribers have PMP-check obligations for opioids. Minnesota's e-prescribing mandate falls on prescribers, with statutory exceptions; pharmacies must accept electronic prescriptions and handle permitted oral or paper exceptions correctly. Theft or significant loss of controlled substances triggers a DEA Form 106 and notice to the Minnesota Board.
Worked example
A prescriber phones in a C-II for 60 tablets. The pharmacist may dispense only the quantity needed for the emergency period, obtain a written or electronic prescription within 7 days, and document the exception. If the follow-up prescription never arrives, the pharmacist must report to DEA.
Traps
Treating federal and Minnesota schedules as identical; refilling a C-II; counting refills beyond six months; forgetting PMP reporting or DEA 106 reporting.